Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Maria Angelica Cantu"'
Publikováno v:
Rheumatology International. 35:265-272
The aim of this study was to validate a novel technique that predicts stopping of disease-modifying anti-rheumatic drugs (DMARDs) and biologic agents (BA) from the Veterans Affairs (VA) database and compare infection risks of rheumatoid arthritis pat
Autor:
Carl E. Allen, M. John Hicks, Maria Angelica Cantu, Kenneth L. McClain, Mrinalini Bilgi, Philip J. Lupo
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 8, p e43257 (2012)
PLoS ONE, Vol 7, Iss 8, p e43257 (2012)
BackgroundThere is little data on treatment of Langerhans cell histiocytosis (LCH) in adults. Available data is on small numbers of patients with short follow-up times and no comparison of results from different treatment regimens. We analyzed the re
Plasma Biomarker Profiling In Langerhans Cell Histiocytosis: Risk-Stratifying The Inflammatory Storm
Autor:
Tsz-Kwong Chris Man, Carl E. Allen, Tricia L. Peters, Miguel Dario Cantu, Rikhia Chakraborty, Kenneth L. McClain, Karen Phaik-Har Lim, Maria Angelica Cantu, Harshal Abhyankar, Albert Shih
Publikováno v:
Blood. 122:2854-2854
Introduction Despite indistinguishable histology and the common feature of Birbeck granules in lesion biopsies, clinical presentation of patients with Langerhans Cell Histiocytosis (LCH) is highly variable, from single lesion cured by curretage, to m